This paper is only available as a PDF. To read, Please Download here.
Young children perceive nociceptive stimuli and experience pain differently than adults,
but the underlying mechanisms that cause these differential effects are unknown. The
result of this uncertainty can lead to incomplete pain management for these patients.
Further, a vulnerable period occurs during early life whereby aversive stimuli can
be biologically encoded possibly through altered neuroimmune and endocrine interactions
that influence sensory responsiveness later in life. We evaluated the role of neuroimmune
and endocrine interactions in early life, and explored the effects on “neonatal priming.”
We assessed pain-like behaviors, sensory neuron response properties with ex vivo electrophysiology,
and dorsal root ganglion (DRG) and macrophage specific gene expression under normal
and/or genetically altered conditions in both uninjured mice and in animals that experienced
surgical hindpaw incisions. We first found that sensory neuron deletion of the receptor
for the endocrine signaling molecule growth hormone (GH), induced pain-like behaviors
in neonates. Acute peripheral sensitization after incision injury was prevented by
local GH treatment, and macrophage ablation of GH receptor also prevented incision-related
effects. Macrophages appear to sequester injury-site GH, which releases a tonic inhibition
on the sensory neurons and drives primary afferent sensitization. Manipulations in
GH signaling or ablating neonatal macrophages was found to be critical for the development
of neonatal priming. New ATAC-seq data indicates differences in chromatin accessibility
in immature macrophages that may underlie how early life neuroimmune interactions
modulate neonatal priming effects. Results demonstrate that the periphery has unique
modulators of neonatal nociception that often require distinct immune cell and endocrine
signaling activities that influence sensory neuron function. We are currently investigating
how altering this process may affect neonatal priming through epigenetic modifications
in macrophages. R01NS105715.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The Journal of PainAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2021 Published by Elsevier Inc.